Godavari Biorefineries Ltd

Godavari Biorefineries Expands into US Pharma Market with New Subsidiary 💊🌎

- Godavari Biorefineries Ltd established Sathgen Therapeutics, LLC in the USA on November 17, 2025.

- The new subsidiary focuses on pharmaceutical marketing with a share capital of US$ 350,000.

- Sathgen will drive business development for drugs developed by Godavari Biorefineries in India.

- The subsidiary is fully owned by Godavari Biorefineries Inc, ensuring direct control over operations.

- Incorporation was conducted independently, without related party transactions or need for regulatory approvals.